Sign up
Pharma Capital
Market: TSX-V:AQS
52-week High/Low: C$0.33 / C$0.13
Sector: Pharma & Biotech
Market Cap: C$16.89M

We are a rapidly growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus’ sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including neurology, ophthalmology and transplant.

Aequus is developing a pipeline of products in neurology and psychiatry with a goal of...

Aequus Pharmaceuticals Inc

Interactive graph

col 3
col 4
col 5
col 6
View full AQS profile View Profile
View All

Executive video interviews


© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.